Croda International

CRDA: 3,109.11 -108.00 (▼3.38%)

Delayed:2016-12-12 18:15:00
Bid Price 3,083.00 High Price 3,197.00
Ask Price 3,085.00 Low Price 3,076.00
Open Price 3,189.00 Spread 0.06%
Prev Close 3,084.00 Volume 491,765.00

Croda International Share Price Chart


Historic – 1 year

Croda International Share Price Information

Name Croda International Epic CRDA
Sector Chemicals ISIN GB00BYZWX769
Activites Croda is a world leader in natural based speciality chemicals which are sold to virtually every type of industry. The company has approximately 3400 employees, working in 34 countries. Activities can be broadly classified into three sectors: Consumer Care which consists of global businesses in personal care, health care and crop care – all markets with an increasing need for innovation and sustainable ingredients. Performance Technologies which comprises home care, additives for polymers, polymers and coatings, lubricant additives, and processed vegetable oils. Industrial Chemicals which consists of base oleochemicals. In addition, the group has an Enterprise Technology function which identifies and integrates new technology into Croda’s global business structure. Security Type Equity

Key numbers

Latest Share Price (p) 3,084.00 Net Gearing (%) 47.79
Market Cap (£m) 4,153.99 Gross Gearing (%) 52.32
Shares in issue (m) 131.25 Debt Ratio 42.74
P/E Ratio 23.74 Debt-to-Equity Ratio 0.68
Divs per share (p) 69.00 Assets / Equity Ratio 2.10
Dividend Yield (%) 2.24 Price to book value 6.84
Dividend Cover 2.02 SROCE (%) 23.79
Earning per share (p) 133.30 EPS Growth (%) 9.35
52-week high / low (p) 3,778.50 / 2,635.00 DPS Growth (%) 5.34

Croda International Broker Views

Date Broker Rec. Price Old target price New target price Notes
30 Nov Deutsche Bank Buy 3,109.11 3600.00 3300.00 Downgrades
21 Nov Goldman Sachs Neutral 3,109.11 3325.00 Initiates/Starts
15 Nov Exane BNP Paribas Underperform 3,109.11 3000.00 3000.00 Reiterates
07 Nov Numis Hold 3,109.11 3419.00 3419.00 Reiterates
03 Nov Liberum Capital Hold 3,109.11 3500.00 3500.00 Reiterates

Croda International Director Deals

Date Director Type Volume / Price Trade Value
01 Nov 2016 Steve Foots Exercise 223 @ 2141.00p £4,774.43
05 Oct 2016 Steve Williams Dividend Reinvestment 102 @ 3609.60p £3,681.79
13 Sep 2016 Jez Maiden Buy 4 @ 3264.00p £130.56
13 Sep 2016 Keith Layden Buy 5 @ 3264.00p £163.20
13 Sep 2016 Steve Foots Buy 5 @ 3264.00p £163.20
11 Aug 2016 Jez Maiden Buy 5 @ 3370.00p £168.50
11 Aug 2016 Keith Layden Buy 4 @ 3370.00p £134.80
11 Aug 2016 Steve Foots Buy 4 @ 3370.00p £134.80

Croda International Company News

Broker Forecast – Deutsche Bank issues a broker note on Croda International PLC

Deutsche Bank today downgrades its investment rating on Croda International PLC (LON:CRDA) to buy (from hold) and cut its price target to 3300p (from 3600p).

Story provided by

Broker Forecast – Goldman Sachs issues a broker note on Croda International PLC

Goldman Sachs today initiates coverage of Croda International PLC (LON:CRDA) with a neutral investment rating and price target of 3325p.

Story provided by

Croda reaffirms FY outlook

Croda International has reaffirmed its full-year outlook after continued profitable growth in the third quarter.

Constant currency sales increased by 2.5% in the quarter and by 2.4% in the year to date.

It says innovation continues to enhance the product portfolio, with New and Protected Products (‘NPP’) accounting for 27.6% of year to date sales (2015: 26.4%). The quarter also benefited from Incotec, the seed enhancement business acquired in December 2015.

Third quarter sales continued broadly in line with first half year trends and profit was in line with our expectations. Sales rose by 20.1% to £315.3 million (Q3 2015: £262.5m).

With over 95% of sales outside the UK, this largely reflected favourable currency translation, with the impact of weaker sterling increasing sales by 17.6%. Year to date sales increased by 11.7% to £924.0m (2015: £827.1 million), with a favourable currency translation impact of 9.3%. Underlying sales in the core business slowed slightly versus the second quarter, down 2.5% in the third quarter and 1.2% lower year to date, predominantly due to the adverse impact of lower pricing for its generic Omega 3 API.

Story provided by

FLASH: Croda reaffirms FY outlook

Story provided by

Broker Forecast – Berenberg issues a broker note on Croda International PLC

Berenberg today reaffirms its hold investment rating on Croda International PLC (LON:CRDA) and raised its price target to 3650p (from 3150p).

Story provided by